# CGMP RE-SUPPLY OF HPV 16L1/16RG1

> **NIH NIH N02** · KINDRED BIO · 2021 · $855,278

## Abstract

The purpose of this task order is to re-supply recombinant human papillomavirus type 16 chimeric L1/L2 virus-like particles (VLPs) for use as a vaccine (HPV16L1/16RG1 VLP vaccine) in ongoing human clinical
trials, through the tasks identified in the Statement of Work, dated 12/18/2020.

## Key facts

- **NIH application ID:** 10490563
- **Project number:** 75N91019D00027-0-759102100001-1
- **Recipient organization:** KINDRED BIO
- **Principal Investigator:** KEVIN LIN
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $855,278
- **Award type:** —
- **Project period:** 2021-02-26 → 2022-02-25

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10490563

## Citation

> US National Institutes of Health, RePORTER application 10490563, CGMP RE-SUPPLY OF HPV 16L1/16RG1 (75N91019D00027-0-759102100001-1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10490563. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*